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ABSTRACT 
Objective: Nanostructured lipid carrier is an emerging lipid-derived delivery system that is rapidly gaining popularity due to the simplicity of the 
manufacturing technique. The primary task in formulating nanoparticles is to optimize the parameters that are involved in the process. The 
rationale behind this study is to optimize the process parameters for the preparation of nanostructured lipid carriers.  
Methods: The optimization of selected techniques hot homogenization with ultra-sonication and melt dispersion technique, was carried out via 
statistical analysis software JMP version 13 Pro using custom design approaches. Sonication time, homogenization speed, stirring rate, and cooling 
temperature were selected as factors for hot homogenization. Stirring speed, stirring time, and dilution volume were the factors deliberated for melt 
dispersion. The impact of these factors on the responses, particle size, and polydispersity index were studied. The nanoparticles were prepared 
according to the ten experimental runs generated by the design. Based on the responses, the design space and optimum framework were selected.  
Results: The prediction profiler indicated maximum desirability at 81% and 80% for hot homogenization and melt dispersion respectively. The 
actual versus predicted plot of particle size indicated a regression coefficient (R2) of 0.98, and a p-value of 0.0001 for hot homogenization and for 
melt dispersion the corresponding values were 0.95 and 0.0003. For the response polydispersity index, these values were 0.92 and 0.0052 for hot 
homogenization and 0.90 and 0.0024 for melt dispersion. 
Conclusion: The endorsing results indicated the authenticity of the model in predicting the significant processing parameters for NLC.  
Keywords: Nanostructured lipid carriers, Hot homogenization with ultrasonication, Melt dispersion, Custom design 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
DOI: http://dx.doi.org/10.22159/ijap.2020v12i6.39565. Journal homepage: https://innovareacademics.in/journals/index.php/ijap  
 
INTRODUCTION  
Nanostructured lipid carriers (NLCs) are lipid form of nanoparticles 
which are popular because of its imperfect matrix core of solid lipid 
and liquid lipid which shield the drug from degradation hence 
improving its stability [1, 2]. The lipids used are of generally 
recognized as safe (GRAS) category which makes it suitable for 
various routes of administration [3, 4]. 
Several established approaches with rational modification in their 
methodology have been developed for controlled synthesis of 
nanoparticles and these approaches can be scaled up [5, 6]. 
Optimization of the parameters involved in the process can yield 
nanoparticles with desired quality attributes [7]. 
Hence in the present investigation, the selection of optimum 
processing parameters for the preparation of NLC was the focal 
point. The two techniques namely hot homogenization technique 
with ultrasonication (HHU) and melt dispersion technique (MDT) 
were adopted for preparing NLCs. 
Hot homogenization technique with ultrasonication and melt 
dispersion technique are considered to be the most recommended 
methods due to a number of advantages such as easy scale-up, 
product stability, and also eluding the use of organic solvents [8, 9]. 
Custom design helps to build an experimental design that considers 
the fixed boundary of budget and time. By using this design we can 
develop a customized framework so that a broad array of challenges 
can be addressed within a specified scheme. JMP Custom designer 
permits the consideration of sample size and power calculation by 
envisaging the alias structure to identify the usefulness through 
design diagnostic capabilities [10]. 
MATERIALS AND METHODS  
Glibenclamide was secured as a gift sample from Mankind Pharma 
India. Stearic acid and oleic acid were furnished by Venus 
Ethoxyethers Pvt. Ltd India. All additional reagents and chemicals 
were of analytical status. JMP version 13 Pro was used for the 
optimization of the parameters. 
Experimental design 
Hot homogenization with ultrasonication and melt dispersion are 
the multifactor approaches that can affect particle size and 
polydispersity index (PDI) of the product. For hot homogenization 
with ultrasonication, factors such as sonication time, 
homogenization speed, stirring rate, and cooling temperature were 
studied on the responses. For the melt dispersion technique, stirring 
speed, stirring time, and dilution volume was chosen as factors. 
Using JMP version 13 Pro, by custom design approach, all factors 
were selected at two levels low (-1) and high level (+1), and one 
centre point, was added which generated ten experimental runs. 
Preparation of placebo nanostructured lipid carriers 
Hot homogenization technique with ultrasonication  
The procedure was carried out at temperatures above the melting 
point of the lipids. The solid lipid (stearic acid) was melted at 
approximately 5-10 °C above its melting point (69.3 °C). This melted 
lipid was dispersed in hot liquid lipid (oleic acid) and this hot 
dispersion was then cascaded to an aqueous phase containing 
surfactant, tween 20 (1.5%) maintained at the same temperature 
(above 69.3 °C) with constant stirring. This resultant dispersion was 
then sonicated and further homogenized using polytron homogenizer 
(Polytron PT 1600 E kinematica homogenizer). This fine emulsion was 
then poured to the petri dish and cooled to get NLCs [11, 12]. The ratio 
of solid lipid to liquid lipid was 70:30. The experimental runs with 
coded and actual values of factors are outlined in table 1. 
Melt dispersion technique 
In the melt dispersion technique, the melted solid lipid (stearic acid) 
along with hot liquid lipid (oleic acid) was poured into the aqueous 
phase containing the surfactant (at the same temperature) under 
stirring to obtain the O/W emulsion [13]. This hot dispersion was 
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stabilized by stirring for specified periods. The dispersion was then 
added drop wise into ice-cold water (approximately 10-15 °C) under 
continuous stirring. Once the dispersion attained room temperature, 
it was filtered and dried [14, 15]. The ratio of solid lipid and liquid 
lipid was 70:30. The experimental runs with coded and actual values 
of factors are depicted in table 2. 
 
Table 1: Formulation chart (homogenization technique) of placebo NLC as per custom design 




-1= 15000 rpm 
0=17500 rpm 
+1=20000 rpm 
-1= 5 min, 
0=7.5 min 
+1=10 min 
-1= ice bath 
+1=Room temperature 
 
1 +1 -1 +1 -1 
2 -1 +1 +1  1 
3 +1 +1 -1  1 
4  0  0  0 -1 
5 +1 -1 -1  1 
6 -1 -1 -1 -1 
7 -1 +1 +1 -1 
8 +1 +1 -1 -1 
9 -1 -1 -1  1 
10 -1 -1 +1  1 
 
Table 2: Formulation chart (melt dispersion technique) of placebo NLC as per custom design 
Run Stirring speed(rpm) Stirring time(min) Dilution volume(ml) 






(-1= 50 ml 
0=75 ml 
+1=100 ml) 
1 +1 +1 -1 
2 +1 +1 +1 
3 -1 +1 +1 
4 +1 +1 -1 
5 -1 -1 -1 
6 +1 -1 +1 
7 +1 -1 +1 
8 -1 -1 -1 
9 -1 +1 +1 
10 0 0 0 
 
Evaluation of blank formulations  
Particle size analysis and PDI 
SZ-100 HORIBA scientific a particle size, zeta potential, and 
molecular weight analyser work on the principle of dynamic light 
scattering (DLS), electrostatic light scattering, and static light 
scattering technique. The theory of dynamic light scattering was 
used to determine the mean particle size and particle size 
distribution of blank NLCs. The samples were diluted with double 
distilled water and particles were measured in triplicate at a 90 °C 
scattering angle and temperature of 25.2 °C [16]. 
Analysis of experimental design  
The result of particle size and PDI of all ten experimental trials were 
substituted into the model and were evaluated further for the 
authenticity of the model fit. The desirability closer to 100 % was 
opted for optimizing the process parameters for the responses 
particle size and polydispersity index [17]. Optimum design space 
was identified and further drug-loaded formulations were prepared 
using the optimized factors. 
Preparation of drug-loaded formulation 
Hot homogenization technique with ultrasonication 
Glibenclamide was added to stearic acid melt and dispersed in hot 
oleic acid; then this dispersion was added to aqueous phase 
containing surfactant, tween 20 with constant stirring. This resultant 
dispersion was then sonicated and further homogenized using a 
polytron homogenizer. The fine emulsion was poured into the petri 
dish and cooled to get the product. 
Melt dispersion technique 
Melted solid lipid containing the drug and hot liquid lipid was 
streamed into the aqueous phase containing tween 20 under stirring 
to achieve the oil in water emulsion. This hot dispersion was 
stabilized by stirring and then the dispersion was added drop wise 
into ice-cold water (approximately 10-15 °C) under continuous 
stirring. Once the dispersion attained room temperature, it was 
filtered and dried to get the product.  
Evaluation of optimized formulations 
Particle size analysis and polydispersity index 
The mean particle size and PDI of optimized drug ladened NLC (GB-
NLCs) were determined by SZ-100 HORIBA Scientific. The samples 
were analysed by the same procedure mentioned for the blank 
formulation [17]. 
Zeta potential  
Zeta potential is a major characterization required for nanoparticles 
to approximate its surface charge. It is an essential parameter in the 
physical stability of NLC. The zeta potential quantification was 
carried out by SZ-100 HORIBA scientific using the principle of 
electrostatic light scattering. The samples diluted with double 
distilled water were placed in the zeta measurement cell. The 
electrophoretic mobility of the nano dispersion was measured using 
laser Doppler velocimetry. 
Drug entrapment efficacy 
The drug entrapment efficacy (EE) was indirectly obtained by 
calculating the concentration of free glibenclamide in the 
supernatant liquid. The optimized GB-NLC (5 mg equivalent) was 
dispersed in methanol and was centrifuged (Remi motors) at 4000 
rpm for 45 min to segregate the entrapped and unentrapped drug. 
The supernatant was collected and suitably diluted with methanol 
and filtered. The filtrate after suitable dilution was measured 
spectrophotometrically for the drug concentration at 300 nm. The 
percentage entrapment efficacy of NLC was computed as follows 
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EE%= the percentage encapsulation efficiency, Wa = total drug 
content of the NLC taken for the study (equivalent to 5 mg), and Wb 
= the quantity of free drug present in the supernatant fluid after 
centrifugation [18]. 
Morphological study 
The topical morphology of optimized GB-NLC was studied 
employing scanning electron microscopy and atomic force 
microscopy.  
Scanning electron microscopy 
The surface morphology of the optimized formulation was studied 
using the scanning electron microscope (SEM) model EVO MA18 
with Oxford EDS (X-act). NLC dispersion was sputtered with gold 
and spread on a sample holder. The images were obtained at a 
voltage of 30 kV, under argon purging [19]. 
Atomic force microscopy  
Innova SPM atomic force microscope was used for obtaining images 
of the samples. Sample tapping mode was used, where the tapping 
mode maps the topography by lightly tapping the exterior with an 
oscillating probe tip. The Z feedback loop was closed to curtail 
changes in the cantilever’s oscillation amplitude with sample surface 
topography. A minimum of 1μm x 1μm area was scanned [20].  
Differential scanning calorimetry 
Thermograms were obtained using DSC-60 calorimeter (Shimadzu), 
the components included a flow controller (FCL 60), a thermal 
analyzer (TA 60), and operating software (TA 60). A sealed 
aluminum pan was availed to place the sample, which was flushed 
with nitrogen (50 ml/min). The sample was scanned at the rate of 10 
°C/min from 20 °C to 300 °C. An empty aluminum pan was used as a 
reference [21]. 
In vitro release study  
In vitro testing of drug release was performed using Franz diffusion 
cell assembly. In this dialysis technique, the cellophane membrane 
(Sigma Aldrich) was mounted across the donor and receptor 
compartment of the assembly, with a diffusion area of 3.14 cm2. The 
receptor compartment was filled with 50 ml phosphate buffer 
solution (PBS) pH 7.4 maintained at 37±0.5 °C temperature, under 
the stirring speed of 600 rpm. NLC equivalent to 5 mg glibenclamide 
was suspended in PBS pH 5.5 and placed in the donor chamber. The 
sample volume of 1 ml was withdrawn at regular time intervals and 
the sink condition was maintained by replacing fresh buffer into the 
receptor compartment. The analysis of samples for glibenclamide 
content was done by UV spectroscopy at λ max of 300 nm. A drug 
dispersion containing 5 mg of drug was studied by the same 
procedure and comparative data was obtained [22, 23]. 
RESULTS AND DISCUSSION  
The primary objective of optimization was to fabricate the best 
formulation under a given set of conditions. Optimization of processing 
conditions always leads to products with reproducible quality attributes. 
So NLCs were prepared using two techniques namely HHU and MDT and 
the optimum processing conditions for the responses such as particle 
size and polydispersity index were analysed. 
Design evaluation 
The responses obtained from the experimental study for the selected 
factors were substituted into experimental design and the model 
was evaluated for its suitability of fit under the processing 
conditions selected. The mean particle sizes for all the ten 
formulations were within the range of 100 to 200 nm for both hot 
homogenization and melt dispersion (table 3). The polydispersity 
index is the indication of particle size distribution in the 
formulation; a narrow distribution is an essential factor to prove its 
efficacy. The polydispersity index ranged from 0.110 to 0.5 for both 
the hot homogenization technique and the melt dispersion 
technique.
 
Table 3: Mean particle sizes and polydispersity indices of the formulations 
Formulation Mean particle size (nm) PDI Mean particle size (nm) PDI 
Hot homogenization Melt dispersion 
F1 131±0.768 0.337±0.796 155±0.033 0.27±0.33 
F2 128±0.673 0.234±0.234 168±0.234 0.129±0.002 
F3 112±0.689 0.28±0.341 170±0.087 0.124±0.012 
F4 126±0.754 0.186±0.367 157±0.122 0.27±0.012 
F5 125±0.987 0.43±0.145 175±0.108 0.247±0.43 
F6 124±0.901 0.129±0.456 178±0.345 0.11±0.017 
F7 133±0.876 0.178±0.364 180±0.098 0.12±0.0321 
F8 119±0.912 0.123±0.312 174±0.087 0.249±0.154 
F9 121±0.980 0.129±0.123 169±0.008 0.126±0.037 
F10 129±0.870 0.27±0.786 175±0.421 0.264±0.0456 
Notes: Data given in mean±SD, n=3 
 
The Analysis of variance (ANOVA) (table 4) gives information about 
effect of each factor, its interactions and the significant levels of 
these factors on the responses. The model fit is first evaluated using 
adjusted R2value and p value [24]. p value of 5% or less by ANOVA 
and values close to one for R2 indicates the level of significance and 
correlation between predicted and actual responses. 
  
Table 4: ANOVA results for particle size and polydispersity index 
Term Prob>|t| 
Particle size PDI 
Hot homogenization technique with ultrasonication 
Sonication time(5,10) <0.0001* 0.0043* 
H speed(15000,20000) 0.0343* 0.1149 
Stirring rate (500,1000) 0.0014* 0.0038* 
Temperature 0.0006* 0.0278* 
Melt dispersion technique 
Stirring speed(600,1000) 0.0428* 0.8351 
Stirring time(10,20) 0.0001* 0.4950 
Dilution volume(50,100) 0.0011* 0.0004* 
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For the hot homogenization technique, all the parameters had a 
significant influence on the response particle size; sonication time 
and temperature showed the highest significance, followed by 
stirring rate and homogenization speed. The polydispersity index 
was highly affected by the stirring rate and sonication time. 
Temperature also had a significant influence but the impact of 
homogenization speed on PDI was not noteworthy as per the 
observations. Shear intensity is an important factor as it causes the 
deformation of particles and may also accelerate the formation of 
foam or aggregation, hence optimum shear intensity is vital for 
attaining the required particle size with satisfactory polydispersity 
index [25]. 
In melt dispersion, the particle size was significantly influenced by 
stirring time, dilution volume, and stirring speed. The polydispersity 
index was significantly influenced only by the dilution factor (≤0.05). 
Stirring time and stirring speed had very less impact on PDI.  
The actual verses prediction plot signifies the effect of the model and 
compares it against the null model. If the points are close to the 
fitted line, with constricted confidence bands the model is 
considered to be a good fit.  
The actual verses prediction plot for the responses particle size and 
PDI of homogenization technique and melt dispersion technique is 
given in fig. 1a, 1b, 2a and 2b. 
 
 
Fig. 1a: Actual vs predicted plots of the particle size for hot homogenization technique 
 
 
Fig. 1b: Actual Vs predicted plots of PDI for hot homogenization technique 
 
 
Fig. 2a: Actual Vs predicted plots of the particle size for melt dispersion technique 
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Fig. 2a: Actual Vs predicted plots of PDI for melt dispersion technique 
 
According to the predictive models of the homogenization technique 
the values got for particle size (p=0.0001, R2=0.98) and PDI 
(p=0.0052, R2=0.92) confirms the validity of the model, data points 
are found to be almost linear for particle size and PDI. 
As per the predictive models of melt dispersion technique, the 
values attained for particle size (p=0.0003, R2=0.95) and PDI 
(p=0.0024, R2=90) indicated that observed values were in close 
conformity with the predicted estimates. The confidence bands of 
PDI were slightly broader compared to that of particle size which 
can be attributed to a few outlier points in the PDI graph. 
Desirability methodology is an influential optimization tool. The 
values vary from 0 to 1. A scale–free value is obtained from response 
transformation [26]. This approach specifies the quality of a process 
or a product that depends on the characteristics of factors chosen. It 
gives the operating conditions that provide the most desirable 
response. The value of desirability close to one is considered to be 
ideal and close to zero is a non-ideal condition [27]. 
The maximum desirability for hot homogenization was observed at 
(0.81) i.e. 81% (fig. 3) at a homogenization speed of 17500 rpm, 
sonication time of 7.5 min, stirring rate of 750 rpm and ice bath 
temperature and the predicted particle size was 126 nm and the 
polydispersity index was 0.190  
For the melt dispersion technique, the maximum desirability was 
(0.804) or 80 % (fig. 4) observed at a stirring speed of 800 rpm, 
stirring time of 15 min, and dilution volume of water 75 ml which 
predicted a particle size of 170 nm and PDI of 0.197. 
 
 
Fig. 3: Prediction profiler of optimized process parameters for hot homogenization technique 
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Prediction expression for particle size  
The prediction expression generated for particle size of NLC 
developed by HHT (equation 1) and MDT (equation 2) shown below 
123.9634615 =-2.28846153846154 *(Stirring rate-750)/250)+(-
1.03846153846154 * (H speed-17500/2500)+5.03846153846154* 
(sonication time-7.5)/2.5)+(-2.63653846153846 * temperature)-Eq. 
(1). 
According to the expression stirring rate, homogenization speed and 
temperature had a negative impact on particle size. An increase in 
these parameters causes a decrease in the particle size. Whereas 
sonication time presented a positive upshot. 
170.514018691589 =+-6.79672897196262 * (stirring time-
15)/5)+-2.04672897196262 * (stirring speed-800)/200)+ 
4.70327102803738 * (dilution volume-75)/25)]-Eq. (2). 
Among the significant factors stirring time, stirring speed showed a 
positive effect and vice versa for dilution volume  
Prediction expression for PDI 
Prediction formula expressed for PDI of NLC developed by HHT 
(equation 3) and MDT (equation 4) is as follows  
0.227367307692308 =+0.0645576923076923* (Stirring rate-750) 
/250)+(-0.0241923076923077 * (H speed-17500)/2500)+ 
0.0626923076923077*(sonication time-7.5)/2.5)+ 
0.0367673076923077* temperature----Eq. (3). 
Stirring rate, sonication time and temperature are factors 
significantly influencing PDI according to the p-value and all these 
values exhibited a positive impact.  
0.19700934579=+0.0071355140186916 * (stirring time-
15)/5)+0.00213551401869159 * (stirring speed-800)/200)+-
0.0703644859813084* (dilution volume-75)/25)]-Eq. (4). 
The expression indicated a negative impact of the significant factor 
dilution volume on PDI  
Characterization of the NLC formulated at optimized process 
parameters  
The optimized drug (glibenclamide 20 mg) loaded NLCs prepared by 
homogenization method (GB-NLC1) and melt dispersion technique 
(GB-NLC2) were assessed for particle size, PDI, zeta potential, drug 
entrapment, SEM, AFM, DSC, and in vitro drug release 
Particle size and polydispersity index  
Particle size determination is one of the important evaluation 
parameters for NLCS; as it pays for greater area and aids for better 
drug absorption. Also particle size and PDI indicates the steadiness 
of the product which is illustrated in fig. 5 and fig. 6 [28]. The 
particle size of (GB-NLC1) and (GB-NLC2) was found to be 
128±0.254 nm and 169±0.435 nm which was within the design 
space. The results of PDI (GB-NLC1: 0.188±0.098; GB-NLC2: 
0.2±0.018) was closer to that predicted and indicates a narrow size 
distribution of the nanoparticles. 
 
 
Fig. 5: Particle size and PDI of optimized formulation GB-NLC1 (mean±SD, n=3) 
 
 
Fig. 6: Particle size and PDI of optimized formulation GB-NLC2 (mean±SD, n=3) 
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The surface charge on the nano carriers is determined by computing the 
zeta potential (ZP). ZP grades electrostatic repulsion amongst similarly 
charged constituent in the dispersion. For nano particles higher zeta 
potential gives stability by avoiding accumulation. Particulates begin to 
aggregate or flocculate when the zeta values are lowered [29]. The zeta 
potential of ≥ 30 mV designates the stability of any dispersed systems. 
The zeta potential of GB-NLC1 and GB-NLC2 was-38.0 mV and-49 mV 
respectively and depicted in fig. 7 and fig. 8. This indicates an effective 
electrostatic repulsion between particles which resulted in the 
separation of the particle and thus preventing agglomeration. 
 
 
Fig. 7: Zeta potential of optimized formulation GB-NLC1 (mean±SD, n=3) 
 
 
Fig. 8: Zeta potential of optimized formulation GB-NLC2 (mean±SD, n=3) 
 
Drug entrapment 
The drug entrapment was observed to be 94.1%±0.678 for GB-NLC1 
and 92.6%±0.456 for GB-NLC2 this may be endorsed to the distorted 
lipid core of optimized NLC due to blending solid lipid with liquid 
lipid. This amalgamation of solid and liquid lipid leads to increased 
loading of drug and minimizes drug expulsion and loss during 
storage. 
Morphological study 
Drug loaded formulations appeared distinct as demonstrated in SEM 
(fig. 9a and fig. 9b) and AFM images (fig. 10a and fig. 10b) and the 
size was in the nano meter range which complies with the particle 
size data derived from dynamic light scattering (DLS) system. Few 
agglomeration seen may be accounted for the sticky nature of the 
lipids in the formulation [30]. 
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Fig. 9a: SEM image of optimized formulation GB-NLC1 
 
 
Fig. 9b: SEM image of optimized formulation GB-NLC2 
 
 
Fig. 10a: AFM image of optimized formulation GB-NLC1 
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Fig. 10b: AFM image of optimized formulation GB-NLC2 
 
Differential scanning calorimetry 
The DSC study was carried out for the optimized GB-NLC1 and GB-
NLC2, glibenclamide, physical mixture (drug, solid lipid, liquid lipid, 
and surfactant), and the thermograms are presented in fig. 11. DSC 
thermograms of GB showed a melting peak at 171.35 °C which is an 
indication of the high crystalline structure of GB. The physical 
mixture showed a peak at 169 °C nearer to the melting peak of GB. 
The peak of optimized GB-NLC1 was seen at 42. 5 °C and that of GB-
NLC2 was at 38.42 °C, which is a clear indication that GB was 
molecularly distributed in the lipid array of the formulated 
optimized NLC. The addition of the drug to the melted lipid and the 
cooling temperature may have contributed to this less ordered 
matrix of the formulation [31]. 
 
 
Fig. 11: DSC thermograms of (1) optimized GB-NLC1, (2) optimized GB-NLC2 (3) glibenclamide, (4) physical mixture 
 
In vitro release study 
The in vitro release characteristics of glibenclamide from optimized 
GB-NLC1 and GB-NLC2 against drug dispersion (GB dispersion was 
used as a reference for comparison) were observed for a period of 8 
h as illustrated in the fig. 12. It is seen that GB released from 
optimized NLC showed an initial quick-release followed by a slow-
release. The initial rapid release of the drug may be due to the 
release of GB from the NLC facet, while at a later juncture GB was 
regularly released from the nucleus of NLCs. The facet drug 
concentration may be attributed to the cooling of particles from 
higher to lower temperatures, which might have promoted the 
accumulation of drug in the outer surface of the formulation leading 
to the preliminary burst release.  
GB dispersion showed a faster release in comparison to the GB-
NLC1, and GB-NLC2. However, the release from GB-NLC1 was 
prolonged up to 93%±0.173 and from GB-NLC2 it was prolonged to 
89.5%±0.707 up to 8 h when compared to the GB dispersion which 
released 92.5%±0.981 in 4 h. This improvement can be attributed to 
the existence of solid and liquid lipid in the NLC system which 
ameliorated the release prospective. 
Ashwini et al. 





Fig. 12: In vitro drug release profile (mean±SD, n=3) 
 
CONCLUSION  
Hot homogenization technique with ultrasonication and melt 
dispersion technique were successfully utilized for the preparation of 
nanostructured lipid carriers. The influence of various parameters 
like sonication time, homogenization speed, stirring rate and 
temperature for hot homogenization technique and stirring speed, 
stirring time, and dilution volume for melt dispersion technique on 
particle size and polydispersity index were methodically studied. 
Optimized parameters generated by the design were employed to 
prepare glibenclamide NLC. The resultant GB-NLC was gauged in 
terms of particle size, electrostatic stability, morphology, the 
crystallinity of the lipid matrix, and drug release profile. The 
affirmative outcome of the study indicated the appropriateness of 
the above design.  
The custom design approach was found to be an effective method for 
obtaining optimized processing parameters for the preparation of 
NLCs. Dependent variables showing the significant influence on 
particle size and poly dispersibility index were identified and 
controlled to obtain optimized formulation. Also the hot 
homogenization and melt dispersion scheme illustrated to produce 
NLCs with good drug loading, controlled release profile, and 
adequate stability. 
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